1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Pharma 4.0 Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Cloud 1.2.3 On-premise 1.3 Market by Application 1.3.1 Global Pharma 4.0 Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Pharmaceutical Industry 1.3.3 IoT Industry 1.3.4 Medical Equipment Industry 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Pharma 4.0 Market Perspective (2017-2028) 2.2 Pharma 4.0 Growth Trends by Region 2.2.1 Pharma 4.0 Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Pharma 4.0 Historic Market Size by Region (2017-2022) 2.2.3 Pharma 4.0 Forecasted Market Size by Region (2023-2028) 2.3 Pharma 4.0 Market Dynamics 2.3.1 Pharma 4.0 Industry Trends 2.3.2 Pharma 4.0 Market Drivers 2.3.3 Pharma 4.0 Market Challenges 2.3.4 Pharma 4.0 Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Pharma 4.0 Players by Revenue 3.1.1 Global Top Pharma 4.0 Players by Revenue (2017-2022) 3.1.2 Global Pharma 4.0 Revenue Market Share by Players (2017-2022) 3.2 Global Pharma 4.0 Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Pharma 4.0 Revenue 3.4 Global Pharma 4.0 Market Concentration Ratio 3.4.1 Global Pharma 4.0 Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Pharma 4.0 Revenue in 2021 3.5 Pharma 4.0 Key Players Head office and Area Served 3.6 Key Players Pharma 4.0 Product Solution and Service 3.7 Date of Enter into Pharma 4.0 Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Pharma 4.0 Breakdown Data by Type 4.1 Global Pharma 4.0 Historic Market Size by Type (2017-2022) 4.2 Global Pharma 4.0 Forecasted Market Size by Type (2023-2028) 5 Pharma 4.0 Breakdown Data by Application 5.1 Global Pharma 4.0 Historic Market Size by Application (2017-2022) 5.2 Global Pharma 4.0 Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Pharma 4.0 Market Size (2017-2028) 6.2 North America Pharma 4.0 Market Size by Country (2017-2022) 6.3 North America Pharma 4.0 Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Pharma 4.0 Market Size (2017-2028) 7.2 Europe Pharma 4.0 Market Size by Country (2017-2022) 7.3 Europe Pharma 4.0 Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Pharma 4.0 Market Size (2017-2028) 8.2 Asia-Pacific Pharma 4.0 Market Size by Country (2017-2022) 8.3 Asia-Pacific Pharma 4.0 Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Pharma 4.0 Market Size (2017-2028) 9.2 Latin America Pharma 4.0 Market Size by Country (2017-2022) 9.3 Latin America Pharma 4.0 Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Pharma 4.0 Market Size (2017-2028) 10.2 Middle East & Africa Pharma 4.0 Market Size by Country (2017-2022) 10.3 Middle East & Africa Pharma 4.0 Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Pfizer Inc 11.1.1 Pfizer Inc Company Detail 11.1.2 Pfizer Inc Business Overview 11.1.3 Pfizer Inc Pharma 4.0 Introduction 11.1.4 Pfizer Inc Revenue in Pharma 4.0 Business (2017-2022) 11.1.5 Pfizer Inc Recent Development 11.2 Abbott Laboratories 11.2.1 Abbott Laboratories Company Detail 11.2.2 Abbott Laboratories Business Overview 11.2.3 Abbott Laboratories Pharma 4.0 Introduction 11.2.4 Abbott Laboratories Revenue in Pharma 4.0 Business (2017-2022) 11.2.5 Abbott Laboratories Recent Development 11.3 GE Healthcare 11.3.1 GE Healthcare Company Detail 11.3.2 GE Healthcare Business Overview 11.3.3 GE Healthcare Pharma 4.0 Introduction 11.3.4 GE Healthcare Revenue in Pharma 4.0 Business (2017-2022) 11.3.5 GE Healthcare Recent Development 11.4 Boston Scientific 11.4.1 Boston Scientific Company Detail 11.4.2 Boston Scientific Business Overview 11.4.3 Boston Scientific Pharma 4.0 Introduction 11.4.4 Boston Scientific Revenue in Pharma 4.0 Business (2017-2022) 11.4.5 Boston Scientific Recent Development 11.5 Medtronic Plc. 11.5.1 Medtronic Plc. Company Detail 11.5.2 Medtronic Plc. Business Overview 11.5.3 Medtronic Plc. Pharma 4.0 Introduction 11.5.4 Medtronic Plc. Revenue in Pharma 4.0 Business (2017-2022) 11.5.5 Medtronic Plc. Recent Development 11.6 Lonza Group AG 11.6.1 Lonza Group AG Company Detail 11.6.2 Lonza Group AG Business Overview 11.6.3 Lonza Group AG Pharma 4.0 Introduction 11.6.4 Lonza Group AG Revenue in Pharma 4.0 Business (2017-2022) 11.6.5 Lonza Group AG Recent Development 11.7 GlaxoSmithKline plc. 11.7.1 GlaxoSmithKline plc. Company Detail 11.7.2 GlaxoSmithKline plc. Business Overview 11.7.3 GlaxoSmithKline plc. Pharma 4.0 Introduction 11.7.4 GlaxoSmithKline plc. Revenue in Pharma 4.0 Business (2017-2022) 11.7.5 GlaxoSmithKline plc. Recent Development 11.8 Koninklijke Philips N.V. 11.8.1 Koninklijke Philips N.V. Company Detail 11.8.2 Koninklijke Philips N.V. Business Overview 11.8.3 Koninklijke Philips N.V. Pharma 4.0 Introduction 11.8.4 Koninklijke Philips N.V. Revenue in Pharma 4.0 Business (2017-2022) 11.8.5 Koninklijke Philips N.V. Recent Development 11.9 Glatt GmbH 11.9.1 Glatt GmbH Company Detail 11.9.2 Glatt GmbH Business Overview 11.9.3 Glatt GmbH Pharma 4.0 Introduction 11.9.4 Glatt GmbH Revenue in Pharma 4.0 Business (2017-2022) 11.9.5 Glatt GmbH Recent Development 11.10 Vertex 11.10.1 Vertex Company Detail 11.10.2 Vertex Business Overview 11.10.3 Vertex Pharma 4.0 Introduction 11.10.4 Vertex Revenue in Pharma 4.0 Business (2017-2022) 11.10.5 Vertex Recent Development 11.11 Johnson & Johnson 11.11.1 Johnson & Johnson Company Detail 11.11.2 Johnson & Johnson Business Overview 11.11.3 Johnson & Johnson Pharma 4.0 Introduction 11.11.4 Johnson & Johnson Revenue in Pharma 4.0 Business (2017-2022) 11.11.5 Johnson & Johnson Recent Development 11.12 Goodly Innovations 11.12.1 Goodly Innovations Company Detail 11.12.2 Goodly Innovations Business Overview 11.12.3 Goodly Innovations Pharma 4.0 Introduction 11.12.4 Goodly Innovations Revenue in Pharma 4.0 Business (2017-2022) 11.12.5 Goodly Innovations Recent Development 11.13 QbDVision 11.13.1 QbDVision Company Detail 11.13.2 QbDVision Business Overview 11.13.3 QbDVision Pharma 4.0 Introduction 11.13.4 QbDVision Revenue in Pharma 4.0 Business (2017-2022) 11.13.5 QbDVision Recent Development 11.14 Electrosan 11.14.1 Electrosan Company Detail 11.14.2 Electrosan Business Overview 11.14.3 Electrosan Pharma 4.0 Introduction 11.14.4 Electrosan Revenue in Pharma 4.0 Business (2017-2022) 11.14.5 Electrosan Recent Development 11.15 GoSilico 11.15.1 GoSilico Company Detail 11.15.2 GoSilico Business Overview 11.15.3 GoSilico Pharma 4.0 Introduction 11.15.4 GoSilico Revenue in Pharma 4.0 Business (2017-2022) 11.15.5 GoSilico Recent Development 11.16 Smart Factory 11.16.1 Smart Factory Company Detail 11.16.2 Smart Factory Business Overview 11.16.3 Smart Factory Pharma 4.0 Introduction 11.16.4 Smart Factory Revenue in Pharma 4.0 Business (2017-2022) 11.16.5 Smart Factory Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Pharma 4.0 Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Cloud Table 3. Key Players of On-premise Table 4. Global Pharma 4.0 Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 5. Global Pharma 4.0 Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Pharma 4.0 Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Pharma 4.0 Market Share by Region (2017-2022) Table 8. Global Pharma 4.0 Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Pharma 4.0 Market Share by Region (2023-2028) Table 10. Pharma 4.0 Market Trends Table 11. Pharma 4.0 Market Drivers Table 12. Pharma 4.0 Market Challenges Table 13. Pharma 4.0 Market Restraints Table 14. Global Pharma 4.0 Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Pharma 4.0 Market Share by Players (2017-2022) Table 16. Global Top Pharma 4.0 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma 4.0 as of 2021) Table 17. Ranking of Global Top Pharma 4.0 Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Pharma 4.0 Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Pharma 4.0 Product Solution and Service Table 21. Date of Enter into Pharma 4.0 Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Pharma 4.0 Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Pharma 4.0 Revenue Market Share by Type (2017-2022) Table 25. Global Pharma 4.0 Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Pharma 4.0 Revenue Market Share by Type (2023-2028) Table 27. Global Pharma 4.0 Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Pharma 4.0 Revenue Market Share by Application (2017-2022) Table 29. Global Pharma 4.0 Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Pharma 4.0 Revenue Market Share by Application (2023-2028) Table 31. North America Pharma 4.0 Market Size by Country (2017-2022) & (US$ Million) Table 32. North America Pharma 4.0 Market Size by Country (2023-2028) & (US$ Million) Table 33. Europe Pharma 4.0 Market Size by Country (2017-2022) & (US$ Million) Table 34. Europe Pharma 4.0 Market Size by Country (2023-2028) & (US$ Million) Table 35. Asia-Pacific Pharma 4.0 Market Size by Region (2017-2022) & (US$ Million) Table 36. Asia-Pacific Pharma 4.0 Market Size by Region (2023-2028) & (US$ Million) Table 37. Latin America Pharma 4.0 Market Size by Country (2017-2022) & (US$ Million) Table 38. Latin America Pharma 4.0 Market Size by Country (2023-2028) & (US$ Million) Table 39. Middle East & Africa Pharma 4.0 Market Size by Country (2017-2022) & (US$ Million) Table 40. Middle East & Africa Pharma 4.0 Market Size by Country (2023-2028) & (US$ Million) Table 41. Pfizer Inc Company Detail Table 42. Pfizer Inc Business Overview Table 43. Pfizer Inc Pharma 4.0 Product Table 44. Pfizer Inc Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million) Table 45. Pfizer Inc Recent Development Table 46. Abbott Laboratories Company Detail Table 47. Abbott Laboratories Business Overview Table 48. Abbott Laboratories Pharma 4.0 Product Table 49. Abbott Laboratories Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million) Table 50. Abbott Laboratories Recent Development Table 51. GE Healthcare Company Detail Table 52. GE Healthcare Business Overview Table 53. GE Healthcare Pharma 4.0 Product Table 54. GE Healthcare Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million) Table 55. GE Healthcare Recent Development Table 56. Boston Scientific Company Detail Table 57. Boston Scientific Business Overview Table 58. Boston Scientific Pharma 4.0 Product Table 59. Boston Scientific Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million) Table 60. Boston Scientific Recent Development Table 61. Medtronic Plc. Company Detail Table 62. Medtronic Plc. Business Overview Table 63. Medtronic Plc. Pharma 4.0 Product Table 64. Medtronic Plc. Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million) Table 65. Medtronic Plc. Recent Development Table 66. Lonza Group AG Company Detail Table 67. Lonza Group AG Business Overview Table 68. Lonza Group AG Pharma 4.0 Product Table 69. Lonza Group AG Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million) Table 70. Lonza Group AG Recent Development Table 71. GlaxoSmithKline plc. Company Detail Table 72. GlaxoSmithKline plc. Business Overview Table 73. GlaxoSmithKline plc. Pharma 4.0 Product Table 74. GlaxoSmithKline plc. Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million) Table 75. GlaxoSmithKline plc. Recent Development Table 76. Koninklijke Philips N.V. Company Detail Table 77. Koninklijke Philips N.V. Business Overview Table 78. Koninklijke Philips N.V. Pharma 4.0 Product Table 79. Koninklijke Philips N.V. Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million) Table 80. Koninklijke Philips N.V. Recent Development Table 81. Glatt GmbH Company Detail Table 82. Glatt GmbH Business Overview Table 83. Glatt GmbH Pharma 4.0 Product Table 84. Glatt GmbH Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million) Table 85. Glatt GmbH Recent Development Table 86. Vertex Company Detail Table 87. Vertex Business Overview Table 88. Vertex Pharma 4.0 Product Table 89. Vertex Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million) Table 90. Vertex Recent Development Table 91. Johnson & Johnson Company Detail Table 92. Johnson & Johnson Business Overview Table 93. Johnson & Johnson Pharma 4.0Product Table 94. Johnson & Johnson Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million) Table 95. Johnson & Johnson Recent Development Table 96. Goodly Innovations Company Detail Table 97. Goodly Innovations Business Overview Table 98. Goodly Innovations Pharma 4.0Product Table 99. Goodly Innovations Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million) Table 100. Goodly Innovations Recent Development Table 101. QbDVision Company Detail Table 102. QbDVision Business Overview Table 103. QbDVision Pharma 4.0Product Table 104. QbDVision Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million) Table 105. QbDVision Recent Development Table 106. Electrosan Company Detail Table 107. Electrosan Business Overview Table 108. Electrosan Pharma 4.0Product Table 109. Electrosan Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million) Table 110. Electrosan Recent Development Table 111. GoSilico Company Detail Table 112. GoSilico Business Overview Table 113. GoSilico Pharma 4.0Product Table 114. GoSilico Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million) Table 115. GoSilico Recent Development Table 116. Smart Factory Company Detail Table 117. Smart Factory Business Overview Table 118. Smart Factory Pharma 4.0Product Table 119. Smart Factory Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million) Table 120. Smart Factory Recent Development Table 121. Research Programs/Design for This Report Table 122. Key Data Information from Secondary Sources Table 123. Key Data Information from Primary Sources List of Figures Figure 1. Global Pharma 4.0 Market Share by Type: 2021 VS 2028 Figure 2. Cloud Features Figure 3. On-premise Features Figure 4. Global Pharma 4.0 Market Share by Application in 2021 & 2028 Figure 5. Pharmaceutical Industry Case Studies Figure 6. IoT Industry Case Studies Figure 7. Medical Equipment Industry Case Studies Figure 8. Others Case Studies Figure 9. Pharma 4.0 Report Years Considered Figure 10. Global Pharma 4.0 Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 11. Global Pharma 4.0 Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Pharma 4.0 Market Share by Region: 2021 VS 2028 Figure 13. Global Pharma 4.0 Market Share by Players in 2021 Figure 14. Global Top Pharma 4.0 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma 4.0 as of 2021) Figure 15. The Top 10 and 5 Players Market Share by Pharma 4.0 Revenue in 2021 Figure 16. North America Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million) Figure 17. North America Pharma 4.0 Market Share by Country (2017-2028) Figure 18. United States Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Canada Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Pharma 4.0 Market Share by Country (2017-2028) Figure 22. Germany Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. France Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. U.K. Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Italy Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Russia Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Nordic Countries Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Pharma 4.0 Market Share by Region (2017-2028) Figure 30. China Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Japan Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. South Korea Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Southeast Asia Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. India Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Australia Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Pharma 4.0 Market Share by Country (2017-2028) Figure 38. Mexico Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Brazil Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Pharma 4.0 Market Share by Country (2017-2028) Figure 42. Turkey Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Saudi Arabia Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Pfizer Inc Revenue Growth Rate in Pharma 4.0 Business (2017-2022) Figure 45. Abbott Laboratories Revenue Growth Rate in Pharma 4.0 Business (2017-2022) Figure 46. GE Healthcare Revenue Growth Rate in Pharma 4.0 Business (2017-2022) Figure 47. Boston Scientific Revenue Growth Rate in Pharma 4.0 Business (2017-2022) Figure 48. Medtronic Plc. Revenue Growth Rate in Pharma 4.0 Business (2017-2022) Figure 49. Lonza Group AG Revenue Growth Rate in Pharma 4.0 Business (2017-2022) Figure 50. GlaxoSmithKline plc. Revenue Growth Rate in Pharma 4.0 Business (2017-2022) Figure 51. Koninklijke Philips N.V. Revenue Growth Rate in Pharma 4.0 Business (2017-2022) Figure 52. Glatt GmbH Revenue Growth Rate in Pharma 4.0 Business (2017-2022) Figure 53. Vertex Revenue Growth Rate in Pharma 4.0 Business (2017-2022) Figure 54. Johnson & Johnson Revenue Growth Rate in Pharma 4.0 Business (2017-2022) Figure 55. Goodly Innovations Revenue Growth Rate in Pharma 4.0 Business (2017-2022) Figure 56. QbDVision Revenue Growth Rate in Pharma 4.0 Business (2017-2022) Figure 57. Electrosan Revenue Growth Rate in Pharma 4.0 Business (2017-2022) Figure 58. GoSilico Revenue Growth Rate in Pharma 4.0 Business (2017-2022) Figure 59. Smart Factory Revenue Growth Rate in Pharma 4.0 Business (2017-2022) Figure 60. Bottom-up and Top-down Approaches for This Report Figure 61. Data Triangulation Figure 62. Key Executives Interviewed

Pfizer Inc Abbott Laboratories GE Healthcare Boston Scientific Medtronic Plc. Lonza Group AG GlaxoSmithKline plc. Koninklijke Philips N.V. Glatt GmbH Vertex Johnson & Johnson Goodly Innovations QbDVision Electrosan GoSilico Smart Factory